€1.000.000,00 Target TCV bei €10.000,00 / Deal mit 20% Flat-First-Contract-Compensation, uncapped = €200.000,00 Bonus exkl. Fixum. Wir sind ein schnell wachsendes SaaS-Unternehmen im Bereich WhatsApp-Marketing und AI getriebenem Omnichannel Customer Support Management. Unsere Plattform hilft Unternehmen dabei,
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Back-end Software Engineer For the Aerospace & Aeronautics Business Line, TXT E SWISS is looking for a Back-end Software Engineer to join its team in Switzerland. The selected candidate will be involved in the development of